Can you take Mounjaro forever? What the evidence says about long-term use

What 'no time limit' really means in practice

The question of whether you can take Mounjaro indefinitely is not the same as asking whether you should. The UK licence for tirzepatide does not cap treatment at one or two years, unlike NICE's recommendation for semaglutide (Wegovy), which is tied to use within a specialist service for a maximum of two years under TA875. That distinction is worth knowing if you are weighing options, and if you want a thorough answer, our page on whether you can take Mounjaro for life covers the evidence and practical considerations in detail.

What the licence does require is that treatment continues to serve a clinical purpose. Your prescriber will look at how much weight you have lost, whether you still meet the eligibility criteria, and whether the medicine is tolerated reasonably well. If any of those answers shifts, the conversation about continuing becomes a real one rather than a formality.

A practical check you can build into any month: weigh yourself on the same morning, before eating, note the number alongside the date, and bring those three months' worth of figures to your next clinical review. It takes under a minute and gives your prescriber something concrete to work with, rather than an impression.

You can read more about how tirzepatide works as a treatment if the mechanism behind long-term use interests you.

What stopping Mounjaro tends to look like

The SURMOUNT-1 trial, published in the New England Journal of Medicine, followed adults on tirzepatide for 72 weeks and saw average weight reductions of around 20–21% at the 15mg dose. A related extension study showed that participants who then stopped the medicine regained a substantial portion of that weight over the following year, while those who stayed on it maintained their results.

This is not unique to tirzepatide, it reflects how obesity works as a condition. The biological signals that drive hunger and fat storage do not disappear because a person has lost weight; they often intensify. Stopping treatment removes the pharmacological counterweight to those signals. That is why many people and their prescribers conclude that staying on the medicine long-term is clinically reasonable, rather than treating it as a course to complete.

None of this means stopping is wrong. Some people reach a stable weight, build sustainable habits, and taper off under supervision with good outcomes. The point is that this is a clinical conversation, not a milestone the calendar decides for you. If you are curious about whether you can stay on Mounjaro forever, our dedicated page covers the practicalities in more detail.

The NICE threshold and what it means for you

NICE's appraisal of tirzepatide (TA1026) includes a specific stopping rule: if you have not lost at least 5% of your starting body weight after six months at the highest tolerated dose, the case for continuing should be reviewed. This is not a punishment, it reflects the principle that a medicine justified by its benefits needs to be delivering them.

For the majority of people on tirzepatide who respond to treatment, this threshold is not a concern. SURMOUNT-1 data showed meaningful weight loss across all active doses. But not everyone responds in the same way, and that variability is exactly why ongoing clinical review matters rather than simply renewing a supply automatically.

On the cost side, private treatment is priced per monthly pen, and if you are wondering whether you can take Mounjaro for just one month, your prescriber can help you think through whether that approach makes sense for your situation. A breakdown of how private pricing works and what it typically covers is available on the weight-loss treatments page.

How clinical oversight shapes the long-term decision

Taking Mounjaro long-term is not a set-and-forget arrangement. At nume, every repeat order is reviewed by a GPhC-registered prescriber before it is approved, a real clinician reads your health information, not an automated system. That review catches things that matter: changes in other medicines you take, new health conditions, whether dose increases are appropriate and supported by evidence.

The question of whether you have to stay on Mounjaro indefinitely is one our prescribers hear regularly, and the honest answer varies by person. What stays constant is that the decision should be made with clinical input, not in isolation. Understanding how to take Mounjaro correctly is also part of making long-term treatment work safely and effectively. If you want to explore whether treatment is right for you now, our clinical team can give you a clear picture based on your own situation.